Antares Pharma, Inc. (ATRS)

Sales/Maturities of Investments

$996.00K

Quarterly · Period ending: · USD

ATRS logo

ATRS Sales/Maturities of Investments

Latest reported$996.00K
ATRS Quarterly Sales/Maturities of Investments ($0.00 → $996.00K)
High-resolution chart · PNG

ATRS sales/maturities of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. Sales/Maturities of Investments — Quarterly (USD)
Period endingSales/Maturities of Investments (USD)
996,000
0
0
0
0
2,000,000
6,000,000
8,500,000
6,000,000
0
0
0
0
0
0
0
0
5,000,000
0
0
0
3,000,000
6,000,000
3,000,000
3,000,000
0
0
3,000,000
3,000,000
3,000,000
6,000,000
9,000,000
6,000,000
9,000,000
12,000,000
3,000,000
0
3,000,000
3,000,000
3,000,000
3,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
953,160
6,273,496
8,788,401
4,887,363
2,690,210
2,684,864
2,900,600
2,904,212
0
0
0
0
1,897,477
6,000,000
6,000,000
6,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,343,400
500,000
600,000
2,000,000
3,048,666
1,600,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.